2-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]ethyl methanesulfonate;1-[2,4-difluoro-5-[2-[(R)-methylsulfinyl]ethoxy]phenyl]piperazine;10-[2-[4-[2,4-difluoro-5-[2-[(R)-methylsulfinyl]ethoxy]phenyl]piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine
C51H58F4N18O9S3 — CID 158373449
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]ethyl methanesulfonate;1-[2,4-difluoro-5-[2-[(R)-methylsulfinyl]ethoxy]phenyl]piperazine;10-[2-[4-[2,4-difluoro-5-[2-[(R)-methylsulfinyl]ethoxy]phenyl]piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine
2-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]ethyl methanesulfonate;1-[2,4-difluoro-5-[2-[(R)-methylsulfinyl]ethoxy]phenyl]piperazine;10-[2-[4-[2,4-difluoro-5-[2-[(R)-methylsulfinyl]ethoxy]phenyl]piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine (PubChem CID 158373449) has the molecular formula C51H58F4N18O9S3 and a molecular weight of 1239.33 g/mol. Its IUPAC name is 2-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]ethyl methanesulfonate;1-[2,4-difluoro-5-[2-[(R)-methylsulfinyl]ethoxy]phenyl]piperazine;10-[2-[4-[2,4-difluoro-5-[2-[(R)-methylsulfinyl]ethoxy]phenyl]piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine.
Molecular Properties
| Compound Name | 2-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]ethyl methanesulfonate;1-[2,4-difluoro-5-[2-[(R)-methylsulfinyl]ethoxy]phenyl]piperazine;10-[2-[4-[2,4-difluoro-5-[2-[(R)-methylsulfinyl]ethoxy]phenyl]piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine |
|---|---|
| PubChem CID | 158373449 |
| Molecular Formula | C51H58F4N18O9S3 |
| Molecular Weight | 1239.33 g/mol |
| Exact Mass | 1238.37 |
| IUPAC Name | 2-[7-amino-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-10-yl]ethyl methanesulfonate;1-[2,4-difluoro-5-[2-[(R)-methylsulfinyl]ethoxy]phenyl]piperazine;10-[2-[4-[2,4-difluoro-5-[2-[(R)-methylsulfinyl]ethoxy]phenyl]piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine |
| SMILES | CS(=O)(=O)OCCn1ncc2c1nc(N)n1nc(-c3ccco3)nc21.C[S@@](=O)CCOc1cc(N2CCN(CCn3ncc4c3nc(N)n3nc(-c5ccco5)nc43)CC2)c(F)cc1F.C[S@@](=O)CCOc1cc(N2CCNCC2)c(F)cc1F |
| InChI | InChI=1S/C25H27F2N9O3S.C13H18F2N2O2S.C13H13N7O4S/c1-40(37)12-11-39-21-14-19(17(26)13-18(21)27)34-7-4-33(5-8-34)6-9-35-23-16(15-29-35)24-30-22(20-3-2-10-38-20)32-36(24)25(28)31-23;1-20(18)7-6-19-13-9-12(10(14)8-11(13)15)17-4-2-16-3-5-17;1-25(21,22)24-6-4-19-11-8(7-15-19)12-16-10(9-3-2-5-23-9)18-20(12)13(14)17-11/h2-3,10,13-15H,4-9,11-12H2,1H3,(H2,28,31);8-9,16H,2-7H2,1H3;2-3,5,7H,4,6H2,1H3,(H2,14,17)/t40-;20-;/m11./s1 |
| InChIKey | GUXDPRQVZQFCOA-MYXWQXKJSA-N |
| XLogP | 3.60 |
| TPSA | 317.84 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 19 |
| Heavy Atoms | 85 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1239.33 |
| LogP ≤ 5 | 3.60 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 27 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Sulfonic_acid_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158373449 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.